These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 25437897)

  • 1. Identification of key binding site residues of MCT1 for AR-C155858 reveals the molecular basis of its isoform selectivity.
    Nancolas B; Sessions RB; Halestrap AP
    Biochem J; 2015 Feb; 466(1):177-88. PubMed ID: 25437897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10.
    Ovens MJ; Davies AJ; Wilson MC; Murray CM; Halestrap AP
    Biochem J; 2010 Jan; 425(3):523-30. PubMed ID: 19929853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition of monocarboxylate transporter 2 (MCT2) by AR-C155858 is modulated by the associated ancillary protein.
    Ovens MJ; Manoharan C; Wilson MC; Murray CM; Halestrap AP
    Biochem J; 2010 Oct; 431(2):217-25. PubMed ID: 20695846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors.
    Le Floch R; Chiche J; Marchiq I; Naiken T; Ilc K; Murray CM; Critchlow SE; Roux D; Simon MP; Pouysségur J
    Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16663-8. PubMed ID: 21930917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular Uptake of MCT1 Inhibitors AR-C155858 and AZD3965 and Their Effects on MCT-Mediated Transport of L-Lactate in Murine 4T1 Breast Tumor Cancer Cells.
    Guan X; Rodriguez-Cruz V; Morris ME
    AAPS J; 2019 Jan; 21(2):13. PubMed ID: 30617815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro and In Vivo Efficacy of the Monocarboxylate Transporter 1 Inhibitor AR-C155858 in the Murine 4T1 Breast Cancer Tumor Model.
    Guan X; Bryniarski MA; Morris ME
    AAPS J; 2018 Nov; 21(1):3. PubMed ID: 30397860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Holistic Evolutionary and 3D Pharmacophore Modelling Study Provides Insights into the Metabolism, Function, and Substrate Selectivity of the Human Monocarboxylate Transporter 4 (hMCT4).
    Papakonstantinou E; Vlachakis D; Thireou T; Vlachoyiannopoulos PG; Eliopoulos E
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.
    Lee JY; Lee I; Chang WJ; Ahn SM; Lim SH; Kim HS; Yoo KH; Jung KS; Song HN; Cho JH; Kim SY; Kim KM; Lee S; Kim ST; Park SH; Lee J; Park JO; Park YS; Lim HY; Kang WK
    Oncotarget; 2016 Jul; 7(28):43492-43503. PubMed ID: 27224918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-dependent growth arrest of leukemia cells by MCT1 inhibition: Feeding Warburg's sweet tooth and blocking acid export as an anticancer strategy.
    Pivovarova AI; MacGregor GG
    Biomed Pharmacother; 2018 Feb; 98():173-179. PubMed ID: 29253765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70).
    Wilson MC; Meredith D; Fox JE; Manoharan C; Davies AJ; Halestrap AP
    J Biol Chem; 2005 Jul; 280(29):27213-21. PubMed ID: 15917240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights.
    Puri S; Juvale K
    Eur J Med Chem; 2020 Aug; 199():112393. PubMed ID: 32388280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the DIDS-binding site of monocarboxylate transporter 1 suggest a homology model of the open conformation and a plausible translocation cycle.
    Wilson MC; Meredith D; Bunnun C; Sessions RB; Halestrap AP
    J Biol Chem; 2009 Jul; 284(30):20011-21. PubMed ID: 19473976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of charged residues in the transmembrane helices of monocarboxylate transporter 1 and its ancillary protein basigin in determining plasma membrane expression and catalytic activity.
    Manoharan C; Wilson MC; Sessions RB; Halestrap AP
    Mol Membr Biol; 2006; 23(6):486-98. PubMed ID: 17127621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocarboxylate Transporters MCT1 and MCT4 Regulate Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells.
    Kong SC; Nøhr-Nielsen A; Zeeberg K; Reshkin SJ; Hoffmann EK; Novak I; Pedersen SF
    Pancreas; 2016 Aug; 45(7):1036-47. PubMed ID: 26765963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the binding moiety mediating the interaction between monocarboxylate transporters and carbonic anhydrase II.
    Noor SI; Dietz S; Heidtmann H; Boone CD; McKenna R; Deitmer JW; Becker HM
    J Biol Chem; 2015 Feb; 290(7):4476-86. PubMed ID: 25561737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PGC-1alpha increases skeletal muscle lactate uptake by increasing the expression of MCT1 but not MCT2 or MCT4.
    Benton CR; Yoshida Y; Lally J; Han XX; Hatta H; Bonen A
    Physiol Genomics; 2008 Sep; 35(1):45-54. PubMed ID: 18523157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells.
    Walters DK; Arendt BK; Jelinek DF
    Cell Cycle; 2013 Oct; 12(19):3175-83. PubMed ID: 24013424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crucial residue involved in L-lactate recognition by human monocarboxylate transporter 4 (hMCT4).
    Sasaki S; Kobayashi M; Futagi Y; Ogura J; Yamaguchi H; Takahashi N; Iseki K
    PLoS One; 2013; 8(7):e67690. PubMed ID: 23935841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homology modeling and site-directed mutagenesis identify amino acid residues underlying the substrate selection mechanism of human monocarboxylate transporters 1 (hMCT1) and 4 (hMCT4).
    Futagi Y; Kobayashi M; Narumi K; Furugen A; Iseki K
    Cell Mol Life Sci; 2019 Dec; 76(24):4905-4921. PubMed ID: 31101938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The loop between helix 4 and helix 5 in the monocarboxylate transporter MCT1 is important for substrate selection and protein stability.
    Galić S; Schneider HP; Bröer A; Deitmer JW; Bröer S
    Biochem J; 2003 Dec; 376(Pt 2):413-22. PubMed ID: 12946269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.